SCHEDULE 13D/AFiled Oct 28, 8:00 PM ET

Neumora Therapeutics, Inc. SCHEDULE 13D/A

ARCH Venture Fund XII, L.P.

Summary not available

This filing does not have a generated research summary. You can still open the original filing and its exhibits.